Regeneron Pharmaceuticals Aktie
538,00
EUR
+13,40
EUR
+2,55
%
605,01
USD
-1,11
USD
-0,18
%
Werbung
Regeneron Pharmaceuticals Aktie Analyse
20.10.17 | Regeneron Pharmaceuticals Underweight | Barclays Capital | |
01.08.17 | Regeneron Pharmaceuticals Underperform | Robert W. Baird & Co. Incorporated | |
07.11.16 | Regeneron Pharmaceuticals Sell | Chardan Capital Markets | |
16.03.16 | Regeneron Pharmaceuticals Sell | Chardan Capital Markets | |
25.01.16 | Regeneron Pharmaceuticals Sell | Chardan Capital Markets | |
05.08.15 | Regeneron Pharmaceuticals Sell | UBS AG | |
11.01.05 | Regeneron Pharmaceuticals Sell | Banc of America Sec. |
Werbung
Werbung